Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
Amicus Therapeutics (Nasdaq: FOLD) has announced it will host a conference call and live audio webcast on Wednesday, November 6, 2024, at 8:30 a.m. ET to discuss financial results for the third quarter ended September 30, 2024. Participants must register online to receive dial-in details. A live webcast and presentation materials will be available through the Investors section of the company's website. The event will be archived for later viewing. Amicus Therapeutics is a global biotechnology company focused on developing medicines for rare diseases.
Amicus Therapeutics (Nasdaq: FOLD) ha annunciato che ospiterà una conference call e un webcast audio live mercoledì 6 novembre 2024, alle 8:30 a.m. ET per discutere i risultati finanziari del terzo trimestre conclusosi il 30 settembre 2024. I partecipanti devono registrarsi online per ricevere i dettagli per la chiamata. Un webcast live e i materiali di presentazione saranno disponibili nella sezione Investitori del sito web dell'azienda. L'evento sarà archiviato per una visualizzazione successiva. Amicus Therapeutics è una compagnia biotecnologica globale focalizzata sullo sviluppo di farmaci per malattie rare.
Amicus Therapeutics (Nasdaq: FOLD) ha anunciado que llevará a cabo una conferencia telefónica y una transmisión web en vivo el miércoles 6 de noviembre de 2024 a las 8:30 a.m. ET para discutir los resultados financieros del tercer trimestre que concluyó el 30 de septiembre de 2024. Los participantes deben registrarse en línea para recibir los detalles de acceso. Una transmisión web en vivo y los materiales de presentación estarán disponibles a través de la sección de Inversores del sitio web de la empresa. El evento se archivará para su visualización posterior. Amicus Therapeutics es una empresa biotecnológica global centrada en el desarrollo de medicamentos para enfermedades raras.
아미쿠스 테라퓨틱스(나스닥: FOLD)는 2024년 11월 6일 수요일 오전 8시 30분 ET에 2024년 9월 30일 종료된 3분기 재무 결과에 대해 논의하기 위한 전화 회의 및 라이브 오디오 웨비캐스트를 개최할 것을 발표했습니다. 참가자들은 전화 접속 세부정보를 받기 위해 온라인으로 등록해야 합니다. 라이브 웨비캐스트와 발표 자료는 회사 웹사이트의 투자자 섹션을 통해 제공됩니다. 이 이벤트는 이후 시청을 위해 아카이브됩니다. 아미쿠스 테라퓨틱스는 희귀 질환 치료제를 개발하는 데 집중하는 글로벌 생명공학 회사입니다.
Amicus Therapeutics (Nasdaq: FOLD) a annoncé qu'il organisera une conférence téléphonique et un webcast audio en direct le mercredi 6 novembre 2024 à 8h30 ET pour discuter des résultats financiers du troisième trimestre clos le 30 septembre 2024. Les participants doivent s'inscrire en ligne pour recevoir les détails de connexion. Un webcast en direct et des documents de présentation seront disponibles dans la section Investisseurs du site web de l’entreprise. L’événement sera archivé pour un visionnage ultérieur. Amicus Therapeutics est une entreprise biopharmaceutique mondiale centrée sur le développement de médicaments pour les maladies rares.
Amicus Therapeutics (Nasdaq: FOLD) hat angekündigt, am 6. November 2024 um 8:30 Uhr ET eine Telefonkonferenz und ein Live-Audio-Webcast abzuhalten, um die finanziellen Ergebnisse für das im September 2024 endende dritte Quartal zu besprechen. Die Teilnehmer müssen sich online registrieren, um die Einwahldetails zu erhalten. Ein Live-Webcast und Präsentationsmaterialien werden im Investorensegment der Unternehmenswebsite verfügbar sein. Die Veranstaltung wird für späteres Ansehen archiviert. Amicus Therapeutics ist ein globales Biotechnologieunternehmen, das sich auf die Entwicklung von Arzneimitteln für seltene Krankheiten konzentriert.
- None.
- None.
PRINCETON, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, November 6, 2024, at 8:30 a.m. ET to discuss financial results for the third quarter ended September 30, 2024.
Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.
An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When will Amicus Therapeutics (FOLD) release Q3 2024 earnings?
How can investors access Amicus Therapeutics (FOLD) Q3 2024 earnings call?
Will Amicus Therapeutics (FOLD) Q3 2024 earnings call be archived?
